Bergamonte® delivers a multi-layered antioxidant story supported by polyphenol analysis, human oxidative-stress biomarkers, and research into inflammatory signaling and the cellular pathways involved in antioxidant defense.
Bergamonte® offers more than a generic polyphenol or ORAC story. Its standardized Calabrian bergamot profile is supported by analytical antioxidant testing, human biomarker research, and mechanistic science, giving product developers several layers of evidence for building antioxidant and oxidative-balance formulations.
Analytical Antioxidant Profile
Laboratory testing has evaluated Bergamonte® across several reactive oxygen and radical categories using full-spectrum ORAC analysis.
Human Oxidative-Stress Research
Human clinical research has measured malondialdehyde, LOX-1, and phosphoPKB as biomarkers associated with oxidative vascular stress.
Cytokine Biomarker Data
A 120-day human study evaluated hs-CRP and TNF-α alongside liver and cardiometabolic measurements.
Multi-Pathway Cellular Science
Research has explored free-radical activity, lipid oxidation, inflammatory signaling, autophagy, and cellular antioxidant defenses.
Antioxidant defense is a coordinated system that helps manage reactive molecules generated through normal metabolism, physical activity, and environmental exposure. Bergamonte® is supported by analytical antioxidant testing, human oxidative-stress biomarkers, and mechanistic research, giving formulators multiple layers of evidence for antioxidant positioning.
Key Clinical Benefits
Bergamot provides a diverse spectrum of naturally occurring polyphenols with demonstrated activity against multiple reactive species in laboratory testing. Full-spectrum antioxidant assays help characterize this broad activity rather than reducing the ingredient’s antioxidant story to a single type of free radical.
Human research on Bergamot Polyphenolic Fraction has measured biomarkers such as malondialdehyde and LOX-1 in the context of vascular oxidative stress. These clinical measurements add an important human-data layer to the antioxidant activity demonstrated through laboratory testing.
Oxidative stress and inflammatory signaling are closely interconnected biological processes. Bergamot research includes human measurements of hs-CRP and TNF-α as well as supporting mechanistic work involving cytokines and NF-κB, helping connect antioxidant defense with maintenance of a balanced inflammatory response.
Human studies across the Bergamonte® research platform have evaluated biomarkers associated with oxidative stress and the body’s antioxidant defenses, including MDA, oxidized LDL, GPx, SOD and related inflammatory markers. The findings provide clinical context for antioxidant-support positioning beyond laboratory antioxidant assays alone.
A 30-day randomized study of 77 participants evaluated BPF alongside placebo and rosuvastatin protocols. BPF-containing groups showed significant reductions in malondialdehyde (MDA), together with changes in LOX-1 and phosphoPKB, three biomarkers examined in relation to oxidative vascular damage.
Why it matters: The study directly measured changes in markers of oxidative vascular stress.
A 12-week observational study evaluated F105, a formulation containing bergamot fruit extract plus nine additional phytoextracts. In the higher-risk subgroup, oxidized LDL decreased 19%, the oxLDL/HDL ratio decreased 25%, and PAI-1 decreased 37%.
Why it matters: The study adds human evidence involving oxidatively modified lipids.
A 120-day BPF study also evaluated inflammatory biomarkers alongside metabolic and liver-related measures. hs-CRP decreased 21.6% and TNF-α decreased 25.7%, providing additional context around the close relationship between oxidative and inflammatory balance.
Why it matters: The longer-term study adds inflammatory context to the antioxidant evidence.
Results reflect the specific formulations, doses, populations and study durations evaluated. Certain protocols included additional ingredients or multi-ingredient formulations; findings should not be attributed interchangeably across all Bergamonte® ingredients.
Antioxidant activity is often reduced to a single laboratory number, but oxidative balance involves a much larger network of reactive species, endogenous antioxidant systems, and cellular signaling pathways. For formulators, the strongest antioxidant stories therefore combine analytical characterization with evidence showing how the ingredient interacts with relevant biological markers.
Bergamonte® offers that broader perspective. Its research includes analytical antioxidant testing, human oxidative-stress biomarkers, inflammatory measurements, and mechanistic studies involving several cellular pathways. This allows antioxidant positioning to serve as a meaningful scientific foundation rather than simply a generic supporting claim.
Bergamonte® goes beyond generic antioxidant positioning with standardized polyphenols, defined phytochemistry, analytical characterization, and human oxidative-stress biomarker research.
Antioxidant support is woven throughout the Bergamonte® platform because polyphenol-rich ingredients have been investigated in relation to oxidative balance, lipid oxidation and vascular and metabolic biomarkers. The options below provide different concentrations and botanical architectures for building antioxidant support into broader finished-product concepts.
let’s get started
Discuss your formulation goals, intended positioning, research needs, and product-development opportunities with the HP Ingredients team.
Schedule Now
Evaluate Bergamonte® for your next product concept with a sample for formulation, compatibility, and product-development testing.
Request Now
Ready to explore how Bergamonte® can support your product pipeline? Contact HP Ingredients for samples, technical documentation, clinical research, formulation guidance, and next-step support.
Contact Us